Mosaic ImmunoEngineering, Inc.
CPMV
$0.53
-$0.05-9.14%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.60% | -37.83% | -21.09% | -40.65% | -35.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.53% | -45.72% | -34.97% | -45.50% | -40.24% |
| Operating Income | 22.53% | 45.72% | 34.97% | 45.50% | 40.24% |
| Income Before Tax | 11.41% | 42.25% | 37.16% | 49.05% | 43.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.41% | 41.44% | 37.16% | 48.24% | 43.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.41% | 41.44% | 37.16% | 48.24% | 43.97% |
| EBIT | 22.53% | 45.72% | 34.97% | 45.50% | 40.24% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 11.24% | 41.38% | 37.09% | 48.28% | 44.03% |
| Normalized Basic EPS | 11.18% | 42.13% | 36.69% | 48.82% | 43.51% |
| EPS Diluted | 11.24% | 41.38% | 37.09% | 48.28% | 48.40% |
| Normalized Diluted EPS | 11.18% | 42.13% | 36.69% | 48.82% | 43.51% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |